Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|HER2-positive Breast Cancer
Interventions: DRUG: Pyrotinib Plus And|DRUG: Trastuzumab|DRUG: Abraxane
Sponsor: Shandong Cancer Hospital and Institute